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Objective: Central venous access is an essential strategy when treating oncology 
patients due to the frequent need to administer chemotherapy or collect blood 
specimens. However, there is a considerable risk of complications. The aim of this 
research was to observe the nature and incidence of complications associated with 
central venous access and fully implanted catheters in pediatric oncology patients, as 
well as their association with clinical and laboratory findings. 
Methodology: In this observational, retrospective and descriptive study, the data was 
collected from medical records of patients aged 0 to 14 years in a referral hospital in the 
extreme south of Santa Catarina and were analysed using the SPSS platform. 
Results: From a total of 145 central catheters, 90 (62,06%) complications were 
identified, 21 (14,5%) infections, where 15 (25,4%) occurred in leukopenic patients (p= 
0,016) and 18 (27,7%) in patients with thrombocytopenia (p<0,001).  Six patients 
(4,1%) developed hematomas at the injection site, all of which occurred in 
thrombocytopenic patients (p=0,008). Among mechanical complications related to 
placement, 2 patients (1,4%) developed pneumothorax, 14 (9,7%) hemorrhages, 2 
(1,4%) catheter breaks and 5 (3,4%) catheter malpositioning. 
Conclusion: In this study it was observed that the most frequent complications are of a 
mechanical and infectious nature. A positive correlation was found between infection, 
leukopenia, and thrombocytopenia. Also, it is worth mentioning how a significant 
number of thrombocytopenic patients developed hematomas. 
 




Central venous access is important in the management of pediatric oncology 
patients as it minimizes the discomfort associated with frequent venipuncture required for 
blood collection and infusions while also providing access to central veins, allowing safe 
infusion of vesicant chemotherapeutic agents(1). Unfortunately, venous accesses are also 
associated with several early and late complications(1). Perioperative complications – such 
as pneumothorax or hemorrhage – are usually related to the technique during insertion or 
anatomy. Later complications, such as infection, dysfunction, or thrombosis are often 
related to patient illness or maintaining access(1). 
There is a wide variety of devices used to facilitate venous access and infusion 
of drugs through a central line. Some devices are external while others are implanted in 
the subcutaneous tissue(2). The increased use of such devices has been advocated for since 
it facilitates medication administration, improves quality of treatment, reduces discomfort 
and anxiety caused by repeated venipuncture pain, and it increases patient’s quality of 
life(3). 
The present study is justified due to the abundant use of venous access in cancer 
patients and the serious consequences complications of its use can generate. With this, 
we seek to identify the most prevalent complications, noted in the studied medical 
records, aiming at increasing staff preparedness for preventing complications that could 
impact patient health. Also, the awareness of what patients are at highest risk to develop 
these types of complications is of scientific relevance to the researched hospital, which 
receives citizens from all surrounding metropolitan regions of Criciúma-SC. Therefore, 
the main objective was to observe the nature and incidence of complications with the use 
of central venous access and a fully implanted catheter in pediatric oncology patients in 
a hospital in the extreme south of Santa Catarina and verifying if there is a correlation 
between these complications and the clinical an laboratory situations of the patients. It 




The present study consists of an observational, retrospective, and descriptive 
analysis of secondary data and a quantitative approach. 
This study included children and adolescents admitted and treated in a hospital 
in the extreme south of Santa Catarina. The inclusion criteria were defined as follows: 
pediatric oncology patients aged 0-14 of both genders, subjected to central venous 
catheter (CVC) placement during their stay, between January 2014 and December 2019. 
Cases in which the CVC placement did not occur at this hospital, as well as cases 
lacking sufficient information for the purposes of this study were both excluded from this 
analysis. 
The population to be sampled was n (236); and n refers to the minimum sample 
size which resulted in 145 cases who were equally distributed in collections of 29 cases 
per year within the 5 years. The minimum sample size was reached, the number of cases 
evaluated was 145. 
  
Assessed variables 
Patient’s age (years), sex (male or female), type of catheter (dual lumen catheter, 
Totally Implanted Venous Access Device or TIVAD and PICC), white blood cell (WBC) 
count (4000-11000/µL), platelet count (150.000 – 400.000/µL), infection (catheter tip 
culture), broken catheter, thrombosis, pneumothorax, hemorrhage, malpositioning, and 
other non-specified complications. 
  
Statistical analysis 
The data was directly collected from the patient’s charts using the collection 
instrument and transferred to the IBM Statistical Package for the Social Sciences (SPSS) 
software version 21.0 for statistical analysis. 
The inferential analysis was made with a significance level α = 0,05 or  95% 
confidence. The investigation of normality was reached with the Kolmogorov-Smirnov 
test. The homogeneity of the quantitative variables was evaluated through the Levene test. 
To verify the association between qualitative variables the Pearson’s chi-squared test was 
used. The mean of the variables was compared using the Student’s T-test. 
The project was approved by the Research and Ethics committee of the HSJ 
(process no. 26647219.0.3001.5364) on 24/06/2020. Data collection started only after 
approval by the referred committees following the norms of Ordinance 466/12 of the 
National Health Council. 
As it is a retrospective study with an investigation of medical records of the 
patients, there is a risk of a minimal loss of information due to loss of confidentiality of 




 The medical records of 236 patients treated by two pediatric oncologists from the 
same hospital were analyzed. Among those, 186 were excluded based on the exclusion 
criteria and only 50 were selected. The data for each venous access used by these patients 
was analyzed, with the final “n” amounting in 145 central accesses. 
 The mean age resulted in 4 years, and the patients’ age ranged between 0,3 and 13 
years old. 26 (52%) were female and 24 (48%) were male. 
Table 01. Complications by type of catheter  
 Type of catheter, n (%)  
p¥  
 
TIVAD Dual lumen catheter Picc  
n = 46 n = 91 n = 8 
Infection 
    
Yes 8 (17,4) 12 (13,2) 1 (12,5) 0,798 
No 38 (82,6) 79 (86,8) 7 (87,5) 
 
Thrombosis 
    
Yes 2 (4,3) - - 0,098 
No 44 (95,7) 91 (100) 8 (100) 
 
Pneumothorax 
    
Yes 1 (2,2) 1 (1,1) - 0,794 
No 45 (97,8) 90 (98,9)  8 (100) 
 
Hemorrhage 
    
Yes 5 (10,9) 7 (7,7) 2 (25,0) 0,354 
No 41 (89,1) 84 (92,3) 6 (75,0) 
 
Hematoma 
    
Yes 2 (4,3) 3 (3,3) 1 (12,5) 0,573 
No 44 (95,7) 88 (96,7) 7 (87,5) 
 
Catheter malpositioning 
    
Yes - 5 (5,5)  - 0,092 
No 46 (100) 86 (94,5)  8 (100) 
 
Broken catheter 
    
Yes 1 (2,2) 1 (1,1) - 0,794 
No 45 (97,8) 90 (98,9) 8 (100) 
 
Non-specified complication 
    
No 40 (87,0) 62 (68,1) 5 (62,5) 0,150 
No progression - - 1 (12,5) 
 
Obstruction 3 (6,5) 7 (7,7) 1 (12,5) 
 
Phlogistic signs 2 (4,3) 15 (16,5) 1 (12,5) 
 
Pulled out - 4 (4,4) - 
 
Extravasation 1 (2,2) 2 (2,2) - 
 
Carotid puncture - 1 (1,1) - 
 
¥Values obtained after applying the likelihood ratio test; Source: Research data, 2020. 
An investigation of the WBC count of patients requiring double lumen central 
lines, TIVADs and PICC was also performed. The WBC count upon the date of 
insertion of double lumen lines was considered since these are limited to use during 
maximum of 14 days. Therefore, WBC count of patients with TIVADs in place longer 
than 14 days was considered upon the date of initial signs of complication. Of the 
analyzed cases 59 (42,1%) had leukopenia at the time of placement (or complication), 
65 (46,4%) presented WBC within the reference values and 16 (11,4%) had 
leukocytosis. 
 The platelet count was also analyzed, 65 (46,1%) presenting thrombocytopenia, 
68 (48,2%) cases within the reference values and 8 (5,7%) presenting thrombocytosis. 
Table 02. Complications vs WBC count 
 WBC count, n (%) 
p¥  Leukopenia Normal Leukocytosis 
 n = 59 n = 65 n = 16 
Infection     
Yes 15 (25,4)b 5 (7,7) 1 (6,3) 0,016 
No 44 (74,6) 60 (92,3) 15 (93,8)  
 
Thrombosis 
    
Yes 1 (1,5) 1 (1,7) - 0,781 
No 64 (98,5) 58 (98,3) 16 (100)  
     
Pneumothorax     
Yes - - 2 (12,5)b 0,012 
No 65 (100) 59 (100) 14 (87,5)  
     
Hemorrhage     
Yes 7 (10,8) 6 (10,2) 1 (6,3) 0,849 
No 58 (89,2) 53 (89,8) 15 (93,8)  
     
Hematoma     
Yes 3 (4,6) 3 (5,1) - 0,471 
No 62 (95,4) 56 (94,9) 16 (100)  
     
Unspecified complications     
No 54 (83,1) 36 (61,0) 12 (75,0) 0,318 
No progression - 1 (1,7) -  
Obstruction 3 (4,6) 6 (10,2) 2 (12,5)  
Phlogistic signs 5 (7,7) 12 (20,3) 1 (6,3)  
Pulled out 2 (3,1) 1 (1,7) 1 (6,3)  
Extravasation 1 (1,5) 2 (3,4) -  
Carotid puncture - 1 (1,7) -  
¥Value obtained after applying the likelihood ratio test.; bLetter indicating statistically significant value 
after residual analysis; Source: Research data, 2020 
  
Table 03. Complications vs Platelet count 







 n = 65 n = 68 n = 8 
Infection     
Yes 18 (27,7)b 3 (4,4) - <0,001 
No 47 (72,3) 65 (95,6) 8 (100)  
 
Thrombosis 
    
Yes 1 (1,5) 1 (1,5) - 0,889 
No 64 (98,5) 67 (98,5) 8 (100)  
     
Pneumothorax     
Yes - 1 (1,5) 1 (12,5) 0,103 
No 65 (100) 67 (98,5) 7 (87,5)  
     
Hemorrhage     
Yes 9 (13,) 5 (7,4) - 0,199 
No 56 (86,2) 63 (92,6) 8 (100)  
     
Hematoma     
Yes 6 (9,2)b - - 0,008 
No 59 (90,8) 68 (100) 8 (100)  
     
Unspecified complications     
No 37 (56,9) 59 (86,8) 7 (87,5) 0,010 
No progression 1 (1,5) - -  
Obstruction 8 (12,3) 3 (4,4) -  
Phlogistic signs 14 (21,5)b 4 (5,9) -  
Pulled out 1 (1,5) 2 (3,1) 1 (12,5)  
Extravasation 3 (4,6) - -  
Carotid puncture - 1 (1,5) -  
¥Value obtained after applying the likelihood ratio test.; bLetter indicating statistically significant value 
after residual analysis; Source: Research data, 2020 
 
 Regarding the type of catheter utilized 46 (31,47%) were TIVAD, 91 (62,8%) 
were dual lumen catheters and 8 (5,5%) were PICC. 
 In relation to the insertion site 62 (42,8%) were placed in the right subclavian 
vein, 48 (33,1%) in the left subclavian vein, 19 (13,1%) in the right internal jugular 
vein, 13(9%) in the left internal jugular vein, 1 (0,7%) in the left axillary vein and 
2(1,4%) in the right basilic vein. 
 When analyzing complications, there were 2 (1,4%) cases of broken catheters, 5 
(3,4%) malpositioned catheters, 2 (1,4%) catheter thrombosis, 2(1,4%) pneumothoraces, 
14 (9,7%) hemorrhages, 6 (4,1%) hematomas and 21 (14,5%) infections. 
 Among the unspecified complications 27 (19,28%) cases were registered the 
most frequent of which were phlogistic signs with 18 cases, 4 patients pulled the 
catheter out, in 3 cases there was leakage or extravasation, 11 catheter obstructions and 
in 1 case the catheter did not progress through the vein. 
 The frequency of complications by type of catheter was similar for each device 
(Table 1) 
 Table 2 shows the number of complications versus the WBC count, with more 
incidence of infection in cases where there was pre-existing leukopenia and more 
pneumothorax in patients with leukocytosis. In table 3 the same data were compared 
with platelet counts, resulting in more infection, hematomas and phlogistic signs in 
patients with thrombocytopenia.  
 In table 4, complications by catheter site were analyzed, resulting in one 
statistically significant result (p=0,018) related to hematoma in axillary accesses. 
Pneumothorax cases only happened in subclavian sites. 
 The types of pathogens in catheter tip cultures were analyzed, resulting in the 
presence of 8 cases of coagulase negative staphylococcus, 4 Klebsiella ozaenae, 4 
Candida non albicans, 2 Staphylococcus aureus, 1 Pseudomonas aeruginosa, 1 
Escherichia coli and 1 Klebsiella pneumoniae. 
 In leukopenic patients’ cultures resulted in 5 (8,5%) cases of coagulase negative 
staphylococcus, 3 (5,1%) Candida non albicans, 2 (3,4%) S. aureus, 2 (3,4%) K. 
ozaenae, 1 (1,7%) P. aeruginosa, 1 (1,7) E. coli and 1 (1,7%) K. pneumoniae. 
 In patients with thrombocytopenia, cultures resulted in 7 (10,8%) cases of 
coagulase negative staphylococcus, 3(4,6%) K. ozanae, 3 (4,6%) non-albicans Candida, 




 The study’s objective was to assess the complications relater to central venous 
access through a retrospective multivariate analysis based on data from medical records. 
 Mechanical complications(4) (hemorrhage, pneumothorax, broken catheter, 
malpositioning) occurred in 15,86% of cases. Previous studies indicate variable 
frequencies of mechanical complications between 1,1 to 18,8%(5,6). This result could 
relate to the increased risk of developing post-surgical complications in this patient 
population(7). 
  Central venous catheter use is a frequent cause of treatment-related morbidity 
and mortality in patients with malignancies, mainly due to infectious complications, 
which are responsible for 10-15% of all nosocomial infections in the USA(7). Within 
this study, infectious complications were present in 14.5% of catheters, this statistic 
proves to be relevant, after all, it approaches the sum of all mechanical complications. 
 The articles that analyze the complications with central venous accesses 
generally address different the insertion sites and type of catheters(5,6,8,9) utilized, which 
in this study had limited significance, after large hospitals have policies and procedures 
which already address complications resulting from these variables by avoiding 
insertion at the femoral site and opting for PICC lines. As well as avoiding mechanical 
complications using bedside ultrasound. 
 While considering individual complications, there was no predominance 
between external or totally implanted catheters (as shown in table 1), consistent with 
what was observed in other studies(1). This suggests that the choice of the device should 
be based on the individual’s treatment needs and the comfort of each patient. 
 Among the insertion sites analyzed, there was one significant correlation 
(p=0,018), the occurrence of hematoma in the axillary access (Table 4). Other studies 
that analyzed peripherally inserted catheters(10) did not observe the same correlation. 
This can be explained by the reduced “n” in this research. Regarding pneumothorax, 
only two cases were found – both occurring in the subclavian site- however there is no 
statistical significance as observed in large studies(5). No other significant data related to 
the insertion sites was found, and this outcome is compatible with larger 
studies(5,8,9,11,12). 
 Comparing complications with patients’ WBC count, 15 (25,4%) cases of 
infection occurred in leukopenic patients (p=0,016) (table 2). Retrospective studies 
observing the same variables also reported more local and systemic infections in these 
populations(1), supporting the hypotheses raised prior to data collection, especially since 
leukopenic patients are more susceptible to opportunistic infectious diseases due to their 
immunological fragility. In this analysis, 2 (12,5%) cases of pneumothorax were 
registered in patients with leukocytosis (p=0,012).  
 Observing complications in relation to platelet count, there is evidence of 
more infection(13), hematomas(14) and phlogistic signs in thrombocytopenic patients 
(p>0,05) (table 3). The decrease in platelet count affects primary coagulation, 
predisposing the formation of hematomas and/or minor hemorrhages, thus, the increase 
in hematomas was already predicted in the hypotheses for these patients. However, 
recent studies(13) also relate thrombocytopenia as an independent risk factor for 
infectious processes. This research affirms this correlation, as infections in patients with 
thrombocytopenia had the lowest p-value in the study (p<0,001). 
 The infections were analyzed by means of catheter tip culture, therefore it was 
possible to ascertain and order the pathogens according to their frequency of 
involvement. Coagulase negative Staphylococcus being the most frequent pathogen, 
present 8 times, followed by Klebsiella ozanae occurring 4 times and Streptococcus 
aureus, 2 times. Other articles have observed the presence of the same bacteria, 
although not in the same proportion(1,15), this can due to a variance of pathogens and 
strains from region and hospital locations. The fungal infections that occurred, were 
caused by the Candida species, which is reaffirmed in other studies(15,16), this is due to 
the fact that this pathogen originates in the mucous membrane flora of a large part of the 
human population(17), causing infections when there is immunologic compromise or 
immunosuppression, as is seen in the patients present in this study.  
 
LIMITATIONS 
 This study had some limitations. First, a retrospective analysis of medical 
records was performed, so each chart contained documentation from different 
professionals, and some complications were charted by professionals who were not 
doctors. In addition, there was no designated section in the medical records for reporting 
a catheter complication, consequently the researchers needed to collect data throughout 
the patients’ documented progression.  
 The diagnosis of central venous catheter infection was considered by means of 
catheter tip culture, as there was no other form of diagnosis in the medical records. 
  
CONCLUSION 
 The analysis carried out in this study suggests that the patient with 
hematological alterations has a higher risk of complications with the use of central 
venous catheters, therefore it would be necessary to be aware of laboratory changes in 
patients using these devices, in order to predict or even prevent such complications.  
 We hope this study will lead the way for larger studies that can include other 
populations, and scientifically prove if there really is correlation between the 
hematological alterations and the complications observed in this study. 
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